RMK Priority Area
Not Relevant
Research Area
Disease Treatment
Disease Area
Diseases of the blood or blood-forming organs
Coagulation defects, purpura or other haemorrhagic or related conditions
Coagulation defects
Investigational Product/ Process /Intervention
Research Level
Clinical Practice
Research Description/ Research Lay Summary
Case series of 9 patients
Research Keyword
Emicizumab; haemophilia A; outcome
Research Objective
We aim to study the clinical outcome in our patients who received emicizumab at a reduced dose due to the paucity of data.
Expected / Actual Date Study Starts - First Enrolment of subject / Collecting data
Nov, 28 2022
Expected / Actual Date Study Completed
Dec, 26 2022
Expected / Actual Duration of Study Enrollment / Data Collection
4 weeks
Subject (Sample Size) Description
Age Range : 18 - 70
Gender : Involve All Gender
Biospecimen Collection & Archiving
-
Current Study Status
Not yet Started
Principal Investigator Information
Dr Andy Tang Sing Ong
HOSPITAL UMUM SARAWAK
Sponsor
HOSPITAL UMUM SARAWAK
Ethical Application Status
Individual Clinical Trial Participant–level Data of Individual Participant Data (IPD) Sharing